Escoda-Francolí J, Rodríguez-Rodríguez A, Pérez-García S, Gargallo-Albiol J, Gay-Escoda C. Dental implications in oral cancer patients. Med Oral Patol Oral Cir Bucal. 2011 Jul 1;16 (4):e508-13.

doi:10.4317/medoral.16.e508

http://dx.doi.org/doi:10.4317/medoral.16.e508

1. Onizawa K, Nishihara K, Yamagata K, Yusa H, Yanagawa T, Yoshida H. Factors associated with diagnostic delay of oral squamous cell carcinoma. Oral Oncol. 2003;39:781-8.
doi:10.1016/S1368-8375(03)00075-7

2. Miller M, Kearney N. Oral care for patients with cancer: a review of the literature. Cancer Nurs. 2001;24:241-54.
doi:10.1097/00002820-200108000-00001
PMid:11502032

3. López-Galindo MP, Bagán JV, Jiménez-Soriano Y, Alpiste F, Camps C. Clinical evaluation of dental and periodontal status in a group of oncological patients before chemotherapy. Med Oral Patol Oral Cir Bucal. 2006;11:E17-21.
PMid:16388287

4. Scully C, Epstein JB. Oral health care for the cancer patient. Eur J Cancer B Oral Oncol. 1996;32B:281-92.
doi:10.1016/0964-1955(96)00037-1

5. Wright WE, Haller JM, Harlow SA, Pizzo PA. An oral disease prevention program for patients receiving radiation and chemotherapy. J Am Dent Assoc. 1985;110:43-7.
PMid:3855918

6. Malik IA, Moid I, Haq S, Sabih M. A double-blind, placebo-controlled, randomized trial to evaluate the role of tetrachlorodecaoxide in the management of chemotherapy-induced oral mucositis. J Pain Symptom Manage. 1997;14:82-7.
doi:10.1016/S0885-3924(97)00018-3

7. Meirovitz A, Kuten M, Billan S, Abdah-Bortnyak R, Sharon A, Peretz T, et al. Cytokines levels, severity of acute mucositis and the need of PEG tube installation during chemo-radiation for head and neck cancer-a prospective pilot study. Radiat Oncol. 2010;5:16.
doi:10.1186/1748-717X-5-16
PMid:20184737    PMCid:2837669

8. Naidu MU, Ramana GV, Rani PU, Mohan IK, Suman A, Roy P. Chemotherapy induced and/or radiation therapy-induced oral mucositis--complicating the treatment of cancer. Neoplasia. 2004;6:423-31.
doi:10.1593/neo.04169
PMid:15548350    PMCid:1531648

9. Lin LC, Que J, Lin LK, Lin FC. Zinc supplementation to improve mucositis and dermatitis in patients after radiotherapy for head-and-neck cancers: a double-blind, randomized study. Int J Radiat Oncol Biol Phys. 2006;65:745-50.
doi:10.1016/j.ijrobp.2006.01.015
PMid:16751063

10. Dazzi C, Cariello A, Giovanis P, Monti M, Vertogen B, Leoni M, et al. Prophylaxis with GM-CSF mouthwashes does not reduce frequency and duration of severe oral mucositis in patients with solid tumors undergoing high-dose chemotherapy with autologous peripheral blood stem cell transplantation rescue: a double blind, randomized, placebo-controlled study. Ann Oncol. 2003;14:559-63.
doi:10.1093/annonc/mdg177
PMid:12649101

11. Scully C, Epstein J, Sonis S. Oral mucositis: a challenging complication of radiotherapy, chemotherapy, and radiochemotherapy. Part 2: diagnosis and management of mucositis. Head Neck. 2004;26:77-84.
doi:10.1002/hed.10326

12. Epstein JB, Epstein JD, Epstein MS, Oien H, Truelove EL. Doxepin rinse for management of mucositis pain in patients with cancer: one week follow-up of topical therapy. Spec Care Dentist. 2008;28:73-7.
doi:10.1111/j.1754-4505.2008.00015.x
PMid:18402621

13. Krajnik M, Zylicz Z, Finlay I, Luczak J, Van Sorge AA. Potential uses of topical opioids in palliative care--report of 6 cases. Pain. 1999;80:121-5.
doi:10.1016/S0304-3959(98)00211-5

14. Wiseman M. The treatment of oral problems in the palliative patient. J Can Dent Assoc. 2006;72:453-8.
PMid:16772071

15. Davies AN, Broadley K, Beighton D. Xerostomia in patients with advanced cancer. J Pain Symptom Manage. 2001;22:820-5.
doi:10.1016/S0885-3924(01)00318-9

16. Kielbassa AM, Hinkelbein W, Hellwig E, Meyer-Lückel H. Radiation-related damage to dentition. Lancet Oncol. 2006;7:326-35.
doi:10.1016/S1470-2045(06)70658-1

17. Jabbari S, Kim HM, Feng M, Lin A, Tsien C, Elshaikh M, et al. Matched case-control study of quality of life and xerostomia after intensity-modulated radiotherapy or standard radiotherapy for head-and-neck cancer: initial report. Int J Radiat Oncol Biol Phys. 2005;63:725-31.
doi:10.1016/j.ijrobp.2005.02.045
PMid:16199308

18. Ship JA, McCutcheon JA, Spivakovsky S, Kerr AR. Safety and effectiveness of topical dry mouth products containing olive oil, betaine, and xylitol in reducing xerostomia for polypharmacy-induced dry mouth. J Oral Rehabil. 2007;34:724-32.
doi:10.1111/j.1365-2842.2006.01718.x
PMid:17824884

19. Guchelaar HJ, Vermes A, Meerwaldt JH. Radiation-induced xerostomia: pathophysiology, clinical course and supportive treatment. Support Care Cancer. 1997;5:281-8.
doi:10.1007/s005200050075
PMid:9257424

20. Fox PC, Van der Ven PF, Baum BJ, Mandel ID. Pilocarpine for the treatment of xerostomia associated with salivary gland dysfunction. Oral Surg Oral Med Oral Pathol. 1986;61:243-8.
doi:10.1016/0030-4220(86)90369-5

21. Fox PC, Atkinson JC, Macynski AA, Wolff A, Kung DS, Valdez IH, et al. Pilocarpine treatment of salivary gland hypofunction and dry mouth (xerostomia). Arch Intern Med. 1991;151:1149-52.
doi:10.1001/archinte.151.6.1149
PMid:2043017

22. Münter MW, Karger CP, Hoffner SG, Hof H, Thilmann C, Rudat V, et al. Evaluation of salivary gland function after treatment of head-and-neck tumors with intensity-modulated radiotherapy by quantitative pertechnetate scintigraphy. Int J Radiat Oncol Biol Phys. 2004;58:175-84.
doi:10.1016/S0360-3016(03)01437-8

23. Meirovitz A, Murdoch-Kinch CA, Schipper M, Pan C, Eisbruch A. Grading xerostomia by physicians or by patients after intensity-modulated radiotherapy of head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2006;66:445-53.
doi:10.1016/j.ijrobp.2006.05.002
PMid:16839705

24. Nishimura Y, Nakamatsu K, Shibata T, Kanamori S, Koike R, Okumura M, et al. Importance of the initial volume of parotid glands in xerostomia for patients with head and neck cancers treated with IMRT. Jpn J Clin Oncol. 2005;35:375-9.
doi:10.1093/jjco/hyi108
PMid:15976068

25. Parliament MB, Scrimger RA, Anderson SG, Kurien EC, Thompson HK, Field GC, et al. Preservation of oral health-related quality of life and salivary flow rates after inverse-planned intensity- modulated radiotherapy (IMRT) for head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2004;58:663-73.
doi:10.1016/S0360-3016(03)01571-2

26. Sciubba JJ, Goldenberg D. Oral complications of radiotherapy. Lancet Oncol. 2006;7:175-83.
doi:10.1016/S1470-2045(06)70580-0

27. Avşar A, Elli M, Darka O, Pinarli G. Long-term effects of chemotherapy on caries formation, dental development, and salivary factors in childhood cancer survivors. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007;104:781-9.
doi:10.1016/j.tripleo.2007.02.029
PMid:17618135